Wang Junyuan Jerry
SEC insider (Form 3/4/5 filer). CIK 0002017749. CEO, ANHEART THERAPEUTICS LTD. at Nuvation Bio Inc. (NUVB). 7 reported Form 4/5 transactions since Sep 2024; latest on Nov 11, 2024. Located in NEW YORK, NY.
Companies Wang Junyuan Jerry has filed insider reports for
- Nuvation Bio Inc. (NUVB): Director, Officer, CEO, ANHEART THERAPEUTICS LTD.
Wang Junyuan Jerry
CIK: 0002017749
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Nuvation Bio Inc.
Discretionary Trading P&L
Holdings
Transaction History (7 total)
- Nov 11, 2024NUVB
Nuvation Bio Inc.
SaleDirect56.4K shares at avg. $2.89$163K - Sep 4, 2024NUVB
Nuvation Bio Inc.
ConversionIndirect1.7M shares- - Sep 4, 2024NUVB
Nuvation Bio Inc.
ConversionDirect2.5M shares- - Sep 3, 2024NUVB
Nuvation Bio Inc.
AwardIndirectWarrants (Right to Buy)
57.6K shares- - Sep 3, 2024NUVB
Nuvation Bio Inc.
AwardDirectSeries A Preferred Stock
25.4K shares- - Sep 3, 2024NUVB
Nuvation Bio Inc.
AwardIndirectSeries A Preferred Stock
17K shares- - Sep 3, 2024NUVB
Nuvation Bio Inc.
AwardDirectWarrants (Right to Buy)
86.5K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Nov 11, 2024 | NUVB Nuvation Bio Inc. | Sale | 56,361 | $2.89 | $162,883 | Direct |
| Sep 4, 2024 | NUVB Nuvation Bio Inc. | Conversion | 1,695,700 | - | $0 | Indirect |
| Sep 4, 2024 | NUVB Nuvation Bio Inc. | Conversion | 2,543,600 | - | $0 | Direct |
| Sep 3, 2024 | NUVB Nuvation Bio Inc. | Award Warrants (Right to Buy) | 57,647 | - | - | Indirect |
| Sep 3, 2024 | NUVB Nuvation Bio Inc. | Award Series A Preferred Stock | 25,436 | - | - | Direct |
| Sep 3, 2024 | NUVB Nuvation Bio Inc. | Award Series A Preferred Stock | 16,957 | - | - | Indirect |
| Sep 3, 2024 | NUVB Nuvation Bio Inc. | Award Warrants (Right to Buy) | 86,471 | - | - | Direct |
1-7 of 7 transactions